Obsidian Therapeutics is developing a new generation of controllable cell and gene therapies to safely and effectively treat serious diseases like cancer using its proprietary cytoDRiVE™ platform to precisely regulate protein levels and activity.
Headquarters: | Cambridge, MA |
Website | www.obsidiantx.com |
Pipeline | Preclinical |
@Obsidian_tx | |
Partners | Celgene |